Welcome to BlogNotions' Life Sciences Blog

The BlogNotions Life Sciences Blog delivers a diverse series of perspectives provided by thought leaders in the life sciences industries. Presented by NetLine, this forum delivers compelling updates on the latest technological advances, discussions of research and findings, best practices for advancing education, implications for the future of various life sciences fields, and much more. Here you can find helpful information, ask questions, and collaborate freely.

Drug Patent Expirations for Feb 23, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. TAMIFLU (oseltamivir phosphate) Roche Patent number: 5,763,483 Expiration Date: Feb 23, 2017 DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs. For more information try […]

Continue Reading

Is Okra Good for Diabetes?

According to a handful of recent studies, okra may reduce symptoms of diabetes – a group of diseases that includes type 1 diabetes, type 2 diabetes, and gestational diabetes.   Diabetes claimed the lives of 75,578 Americans in 2013, according to the United States Centers for Disease Control and Prevention (CDC). In 2014,8.5 percent of adults worldwide had the […]

Continue Reading

Broccoli sprout extract may protect against oral cancer recurrence

It is the first study demonstrating that the extract protects against oral cancer, with the results of human, animal and laboratory tests reported in the journalCancer Prevention Research. This research is funded through Pitt’s Specialized Program of Research Excellence grant in head and neck cancer from the National Cancer Institute. “With head and neck cancer, […]

Continue Reading

Scientists streamline total synthesis of uncialamycin drug

A team led by Rice University scientists has improved the production of a potent anti-tumor antibiotic known as uncialamycin. The Rice lab of synthetic chemist K.C. Nicolaou announced this month it had streamlined the total synthesis of uncialamycin to make it simpler to create novel variations of the molecule. Such variations could allow the substance, […]

Continue Reading

Paclitaxel drug may promote cancer spread at low doses

In continuation of my update on paclitaxel New research indicates that paclitaxel, which is the most commonly used chemotherapy for breast cancer, suppresses tumors when given at a certain dosage, but at low doses, it actually promotes cancer spread to the liver. The findings suggest that lowering the dose of paclitaxel to reduce toxic side-effects […]

Continue Reading

Novel combination therapy shows strong response in phase 1 trial

In continuation of my update on Sorafenib, Premetrexed,  Vandetanib“Though phase 1 studies are designed to evaluate the safety of a new therapy, we had strong preclinical evidence suggesting this novel drug combination could work against a variety of cancers, so we hoped that we would see a response in our patients in this early phase […]

Continue Reading

More reasons to eat your broccoli

In continuation of my update on broccoli University of Illinois researchers have identified candidate genes controlling the accumulation of phenolic compounds in broccoli. Consumption of phenolic compounds, including certain flavonoids, is associated with a lower risk of coronary heart disease, type II diabetes, asthma, and several types of cancer. “Phenolic compounds have good antioxidant activity, […]

Continue Reading

Compound shown to reduce brain damage caused by anesthesia in early study

An experimental drug prevented learning deficits in young mice exposed repeatedly to anesthesia, according to a study led by researchers from NYU Langone Medical Center and published June 22 in Science Translational Medicine. The study results may have implications for children who must have several surgeries, and so are exposed repeatedly to general anesthesia. Past studies […]

Continue Reading